Amiodarone Infusion Titration for Atrial Fibrillation
For atrial fibrillation, administer intravenous amiodarone as a 150 mg bolus over 10 minutes, followed by 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours, with a total first 24-hour dose of approximately 1000 mg. 1
Initial Loading Strategy
The FDA-approved dosing regimen provides the foundation for titration:
- Loading bolus: 150 mg IV over 10 minutes
- Fast infusion phase: 1 mg/min (360 mg) for 6 hours
- Slow maintenance phase: 0.5 mg/min (720 mg) for 18 hours
- Total 24-hour dose: ~1000 mg
This regimen can be repeated with additional 150 mg boluses over 10 minutes if breakthrough episodes occur 1. The guidelines specify this same dosing for life-threatening arrhythmias, and while atrial fibrillation is an off-label indication, the dosing framework remains consistent 2.
Critical Administration Requirements
Use a volumetric infusion pump—never use drop counters, as surface tension changes can result in up to 30% underdosing 1. This is a common and dangerous pitfall.
Concentration matters for vein preservation:
- For peripheral IV: Keep concentration ≤2 mg/mL to minimize phlebitis risk
- For central line: Can use up to 6 mg/mL concentrations
- Infusions >1 hour at concentrations >2 mg/mL require central venous access 1
The research evidence shows superficial phlebitis occurred in 13 patients with IV administration 3, reinforcing the importance of proper concentration management.
Maintenance Beyond 24 Hours
After the initial 24 hours, continue at 0.5 mg/min (720 mg/24 hours) for up to 2-3 weeks regardless of age, renal function, or left ventricular function 1. The maintenance rate can be increased to achieve better arrhythmia suppression, though controlled trials showed mean daily doses above 2100 mg increased hypotension risk 1.
Monitoring for Adverse Effects
Watch for hypotension closely—this occurred in 16% of patients in clinical trials 2. The hypotension risk is dose-related and can occur rapidly, particularly with:
- Initial infusion rates >30 mg/min (never exceed this) 1
- Bolus administration
- Patients with baseline hemodynamic compromise
Monitor for bradycardia and AV block, which are common acute effects 2. Keep atropine and pacing capability readily available.
Conversion to Oral Therapy
When transitioning from IV to oral amiodarone:
- <1 week IV therapy: Start 800-1600 mg/day oral
- 1-3 weeks IV therapy: Start 600-800 mg/day oral
- >3 weeks IV therapy: Start 400 mg/day oral 2
Expected Time to Conversion
Antiarrhythmic effects begin within 30 minutes of IV administration 2. Research shows mean conversion time of 12±8 hours with IV administration versus 20±4.5 hours with oral loading 3. Most conversions occur after 6-8 hours of therapy initiation 4. One study using higher infusion rates (1.5 mg/kg/h) achieved 86.7% conversion 5.
Special Considerations
Avoid in Wolff-Parkinson-White with preexcited AF: While recent systematic review data suggest VF risk may be lower than historically reported (0.12-0.68%) 6, and some retrospective series show safe use 7, current guidelines still contraindicate IV amiodarone in this population. Use procainamide or direct cardioversion instead.
Patient selection matters: Amiodarone is particularly appropriate for AF patients with structural heart disease, left ventricular dysfunction, or rapid ventricular rates where Class IC agents are contraindicated 2, 4. However, it should be second-line in patients without structural heart disease 2.
Do not exceed initial infusion rate of 30 mg/min—faster rates have caused hepatocellular necrosis and acute renal failure leading to death 1.